Conference
Benralizumab Significantly Reduced Oral Corticosteroid Dosages And Asthma Exacerbation Rates For Patients With Severe, Uncontrolled Asthma: Results Of The Zonda Phase Iii Trial
Authors
Nair P; Wenzel SE; Rabe K-F; Bourdm A; Lugogo N; Kuna P; Barker P; Sproule S; Ponnarambil S; Goldman M
Volume
195
Publisher
AMER THORACIC SOC
Publication Date
January 1, 2017
Name of conference
International Conference of the American-Thoracic-Society (ATS)
Conference place
Washington, DC
Conference start date
May 19, 2017
Conference end date
May 24, 2017
Conference proceedings
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN
1073-449X